Navigation Links
Dendreon Announces Webcast Presentation at Newsmakers in the Biotech Industry Conference
Date:8/29/2008

SEATTLE, Aug. 29 /PRNewswire-FirstCall/ -- Dendreon Corporation (Nasdaq: DNDN) today announced that Greg Schiffman, chief financial officer of Dendreon, will present a company update at the Newsmakers in the Biotech Industry Conference in New York City, on Thursday, September 4, 2008 at 3:55 p.m. ET.

A live audio webcast of the presentation will be accessible through the Investor Relations section of the Dendreon website, http://www.dendreon.com. If you are unable to listen to the live webcast, it will be archived on the site following the presentation. To access the replay, go to the Investor Relations section of the website.

Dendreon Corporation is a biotechnology company whose mission is to target cancer and transform lives through the discovery, development and commercialization of novel therapeutics. The Company applies its expertise in antigen identification, engineering and cell processing to produce active cellular immunotherapy product candidates designed to stimulate an immune response. Dendreon is also developing an orally-available small molecule called Trp-p8 that could be applicable to multiple types of cancer as well as benign prostatic hyperplasia. The Company has its headquarters in Seattle, Washington and is traded on the Nasdaq Global Market under the symbol DNDN. For more information about the Company and its programs, visit http://www.dendreon.com.


'/>"/>
SOURCE Dendreon Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1

Related biology technology :

1. Dendreon Initiates Second of Two New Phase 2 Trials of PROVENGE for Prostate Cancer
2. Dendreon Reports First Quarter 2008 Financial Results
3. Dendreon Announces Webcast Presentations at Upcoming Investor Conferences
4. Dendreon Announces Closing of Registered Direct Offering
5. Dendreon Announces $47 Million Registered Direct Offering
6. Dendreon Reports Fourth Quarter and 2007 Year End Financial Results
7. FDA Agrees to Amend Dendreons Special Protocol Assessment for Phase 3 IMPACT Study of PROVENGE
8. -Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET-
9. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
10. Dendreon Announces Webcast Presentation at BIO CEO & Investor Conference
11. Dendreon Promotes Dr. Mark Frohlich to Senior Vice President of Clinical Affairs and Chief Medical Officer

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)... California waste-to-energy firm claims first p...teration, smallest footprint, salable pure gas, by... (PRWEB) December 15, 2009 -- The...ative organic waste-to-energy process will take pl...nuary. , , ,This biowaste process known as VRAD&c...
(Date:11/30/2009)... Ohio, Nov. 30 The Ohio Capital Fu...tion,s first minority business early-stage capital...mber 3, is called "Transforming the Landscape of B...e Capital Summit." It will feature several speaker...leaders and local minority entrepreneurs. ,, "...
(Date:11/30/2009)...NG OF PRUSSIA, Pa., Nov. 30 Cadie...izing in interactive marketing services and solut...the launch of its HATCH Consulting services ...ing strategic experts across a range of emerging a...onsulting team is committed to guiding companies a...
(Date:11/30/2009)... Nov. 30 The Michael J....day announced $1.5 million in total awards to six ...ase-modifying therapies for Parkinson,s disease. T... to Drug Discovery for Parkinson,s Disease progra... plc (NYSE: ELN ), a neuroscience-based biotechn...
Breaking Biology Technology:First Public Showing of Innovative Waste-to-Energy Process 2Ohio Capital Fund Announces Sponsorship of Minority Business Conference 2Cadient Interactive Announces the Launch of HATCH Consulting Services 2Cadient Interactive Announces the Launch of HATCH Consulting Services 3The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 2The Michael J. Fox Foundation Announces $1.5 Million in Funding to Advance Development of Drug Targets for Disease-Modifying Parkinson's Disease Treatments 3
... PARIS, May 18 The Institut Pasteur and Merie...ong-term research partnership. , The Institut ...companies:,bioMerieux, Transgene, Shantha Biotechn...sources and efforts to fight infectious diseases t...wing fields: , , - Clinical diagnostics and the...
... Can Be Used by the Elderly and Patients With Move...are Settings , , HAIFA, Israel, May 18 Millions ...at affect their ability to walk. For many of them,...s are a disappointing substitute for being able to...ere,s a high-tech yet easy-to-use gait-training de...
... BALTIMORE, May 18 Paragon Bioservices, Inc., a c...RO/CMO), has been awarded the coveted 2009 Lilly G...n support of Lilly,s strategic objectives. , , "I... by such an elite organization and it provides sol...es of quality, excellence and superior customer se...
Other Biology Technology:The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 2The Institut Pasteur and Merieux Alliance Take First Step Towards a Long-Term Research Partnership in the Field of Infectious Diseases 3Now Available: State-of-the-Art Gait Training Device to Help Millions Walk More Normally Again 2
(Date:11/30/2009)...elpings of gravy and dessert at the holiday table ...viously thought. According to a new research repor... ( http://www.fasebj.org ), a diet that is high in...ultimately cause our bodies to store too much fat....my as the already difficult task of converting hig...
(Date:11/30/2009)...LA Researchers from LSU Health Sciences Center Ne...Shriver National Institute of Child Health and Hum...ealth, Brigham and Women,s Hospital, and Harvard M...drinking more than 5 servings of sugar- sweetened ...antly elevate the risk of developing diabetes duri...
(Date:11/30/2009)...peratures continue to rise scientists are presente...species respond and adapt. In a paper published in... Rodriguez-Trelles and Dr Miguel Rodriguez assess ...ng of approximately 0.6˚C has already affecte...cing ecologists and evolutionary biologists is to ...
Breaking Biology News(10 mins):Happy holidays from the groaning board; Western diets turn on fat genes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 2Sugary cola drinks linked for first time to higher risk of gestational diabetes 3How can scientists measure evolutionary responses to climate change? 2Special One Day Rates Available For DIA 45th Annual Meeting June 21 25 in San Diego 49108 1Special One Day Rates Available For DIA 45th Annual Meeting June 21 25 in San Diego 49108 2Breast Cancer TV Spot Wins Four Telly Awards 49104 1Breast Cancer TV Spot Wins Four Telly Awards 49104 2Strides Made in Hemophilia Research 49100 1Strides Made in Hemophilia Research 49100 2
...be looking at you, but are they really paying atte...ttention, without moving their eyes" Dr. Brian Co...versity of Western Ontario in London, Canada has f... His research Neuromuscular consequences of refle...ine Publication of "Nature Neuroscience". , Our ...
...als from a key molecular receptor that normally sw...ad becomes too intense in the presence of stress a...is (NEC), a leading cause of death in premature ne...ciety for Cell Biology 47th annual meeting. , Dav...ens Hospital of Pittsburgh report that neonatal mi...
... and mineralogy are scientific fields that have be...ge and technologies. The boundary of water and roc...w field of nanoparticle science. , Scientists are... 100 nanometers, influence natural and engineered ...ar materials of a larger size. Nanoparticles are i...
Other Biology News:Leading cause of death in 'preemies' might be controlled by resetting a molecular switch 2Between water and rock -- a new science 2Between water and rock -- a new science 3Between water and rock -- a new science 4Between water and rock -- a new science 5
Bromophenol Blue from USB Corp.
...Oligo Microarray, 22K enables researchers to simul...ociated with biological functions, growth processe...croarray contains sequences representing estimated...uses on well annotated genes selected by Dr. Shosh...
...ax DW4 liquid handling system from Molecular Devic...g all in one instrument. The system handles a vari...ing96-, 384- and 1536-welland is the first to hand...een optimized to dispense from four different chan...
...escence Test Plate consists of an anodized aluminu...Fluorescent Compounds embedded in polymerized matr...d Synergy Multi-Detection Readers. This multi-func...e reducing the need for tedious wet testing. Works...
Biology Products: